TuHURA Biosciences, Inc. HURA
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -10.30% | -- | -- | -- | -117.08% |
| Total Depreciation and Amortization | 28.57% | -- | -- | -- | -29.93% |
| Total Amortization of Deferred Charges | -7.56% | -- | -- | -- | 89.53% |
| Total Other Non-Cash Items | 71.35% | -- | -- | -- | 294.71% |
| Change in Net Operating Assets | -220.24% | -- | -- | -- | 889.65% |
| Cash from Operations | -76.57% | -- | -- | -- | -40.94% |
| Capital Expenditure | -206.60% | -- | -- | -- | 8.53% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 100.00% | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 97.08% | -- | -- | -- | -9,510.76% |
| Total Debt Issued | -30.53% | -- | -- | -- | -56.33% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 21.80% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -100.00% | -- | -- | -- | -- |
| Other Financing Activities | 68.59% | -- | -- | -- | -286.49% |
| Cash from Financing | 10.06% | -- | -- | -- | 0.35% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -97.90% | -- | -- | -- | -145.98% |